{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T07:45:41Z","timestamp":1794642341513,"version":"4.9.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["gimjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genetics in Medicine"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1038\/s41436-020-01080-y","type":"journal-article","created":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T13:21:25Z","timestamp":1611580885000},"page":"845-855","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Transforming the clinical outcome in CRIM-negative infantile Pompe disease identified via newborn screening: the benefits of early treatment with enzyme replacement therapy and immune tolerance induction"],"prefix":"10.1016","volume":"23","author":[{"given":"Cindy","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit K.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Punita","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Dempsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Bhambhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Hopkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Ficicioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranoot","family":"Tanpaiboon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Craigen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy S.","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8251-909X","authenticated-orcid":false,"given":"Priya S.","family":"Kishnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41436-020-01080-y_bb0010","unstructured":"Hirschhorn, R. & Reuser, A. in The Metabolic and Molecular Bases of Inherited Disease 8th edn (eds Scriver, C. R., Beaudet, A. L., Sly, W. S. & Valle, D.) Glycogen storage disease type II; acid \u03b1-glucosidase (acid maltase) deficiency (McGraw-Hill, New York, 2001)."},{"key":"10.1038\/s41436-020-01080-y_bb0015","author":"van den Hout"},{"key":"10.1038\/s41436-020-01080-y_bb0020","author":"Kishnani"},{"key":"10.1038\/s41436-020-01080-y_bb0025","author":"Kishnani"},{"key":"10.1038\/s41436-020-01080-y_bb0030","author":"Amalfitano"},{"key":"10.1038\/s41436-020-01080-y_bb0035","author":"Nicolino"},{"key":"10.1038\/s41436-020-01080-y_bb0040","author":"Kishnani"},{"key":"10.1038\/s41436-020-01080-y_bb0045","author":"Parini"},{"key":"10.1038\/s41436-020-01080-y_bb0050","author":"Prater"},{"key":"10.1038\/s41436-020-01080-y_bb0055","author":"Banugaria"},{"key":"10.1038\/s41436-020-01080-y_bb0060","author":"van Gelder"},{"key":"10.1038\/s41436-020-01080-y_bb0065","author":"Berrier"},{"key":"10.1038\/s41436-020-01080-y_bb0070","author":"Kishnani"},{"key":"10.1038\/s41436-020-01080-y_bb0075","author":"Chien"},{"key":"10.1038\/s41436-020-01080-y_bb0080","author":"Yang"},{"key":"10.1038\/s41436-020-01080-y_bb0085","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/s41436-019-0738-0","article-title":"Higher dosing of alglucosidase alfa improves outcomes in children with Pompe disease: a clinical study and review of the literature","volume":"22","author":"Khan","year":"2020","journal-title":"Genet. Med."},{"key":"10.1038\/s41436-020-01080-y_bb0090","author":"Landis"},{"key":"10.1038\/s41436-020-01080-y_bb0095","author":"Case"},{"key":"10.1038\/s41436-020-01080-y_bb0100","author":"Broomfield"},{"key":"10.1038\/s41436-020-01080-y_bb0105","first-page":"100475","article-title":"Cross-reactive immunologic material positive infantile Pompe disease: characterization of immune responses in patient treated with enzyme replacement therapy","volume":"20","author":"Desai","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1038\/s41436-020-01080-y_bb0110","author":"Desai"},{"key":"10.1038\/s41436-020-01080-y_bb0115","author":"Banugaria"},{"key":"10.1038\/s41436-020-01080-y_bb0120","author":"Kazi"},{"key":"10.1038\/s41436-020-01080-y_bb0125","author":"Mendelsohn"},{"key":"10.1038\/s41436-020-01080-y_bb0130","author":"Messinger"},{"key":"10.1038\/s41436-020-01080-y_bb0135","author":"Chien"},{"key":"10.1038\/s41436-020-01080-y_bb0140","author":"van Gelder"},{"key":"10.1038\/s41436-020-01080-y_bb0145","author":"Bali"},{"key":"10.1038\/s41436-020-01080-y_bb0150","author":"Young"},{"key":"10.1038\/s41436-020-01080-y_bb0155","author":"Chien"},{"key":"10.1038\/s41436-020-01080-y_bb0160","author":"Chien"},{"key":"10.1038\/s41436-020-01080-y_bb0165","author":"Kruskal"},{"key":"10.1038\/s41436-020-01080-y_bb0170","unstructured":"JMP Pro\u00ae [computer program]. Version 15 (SAS Institute Inc. Cary, North Carolina, USA, 1989-2020)."},{"key":"10.1038\/s41436-020-01080-y_bb0175","author":"Adams"},{"key":"10.1038\/s41436-020-01080-y_bb0180","author":"Vogel"},{"key":"10.1038\/s41436-020-01080-y_bb0185","author":"Young"},{"key":"10.1038\/s41436-020-01080-y_bb0190","author":"Thurberg"},{"key":"10.1038\/s41436-020-01080-y_bb0195","author":"Swift"},{"key":"10.1038\/s41436-020-01080-y_bb0200","author":"Fecarotta"},{"key":"10.1038\/s41436-020-01080-y_bb0205","author":"Desai"},{"key":"10.1038\/s41436-020-01080-y_bb0210","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13023-016-0446-7","article-title":"Slow, progressive myopathy in neonatally treated patients with infantile-onset Pompe disease: a muscle magnetic resonance imaging study","volume":"11","author":"Peng","year":"2016","journal-title":"Orphanet J. Rare Dis."}],"container-title":["Genetics in Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41436-020-01080-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41436-020-01080-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360021014519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360021014519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41436-020-01080-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:53:14Z","timestamp":1761097994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098360021014519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S1098360021014519"],"URL":"https:\/\/doi.org\/10.1038\/s41436-020-01080-y","relation":{},"ISSN":["1098-3600"],"issn-type":[{"value":"1098-3600","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transforming the clinical outcome in CRIM-negative infantile Pompe disease identified via newborn screening: the benefits of early treatment with enzyme replacement therapy and immune tolerance induction","name":"articletitle","label":"Article Title"},{"value":"Genetics in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41436-020-01080-y","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021, The Author(s), under exclusive licence to the American College of Medical Genetics and Genomics","name":"copyright","label":"Copyright"}]}}